Bone metastasis is a common complication in cancer and occurs in 70% of patients of breast and prostate cancer. The major clinical manifestations of bone metastases are increased morbidity associated with bone pain, skeletal fractures, hypercalcemia, and spinal cord compression. The focus of our research is to uncover novel pathways essential for regulation of cancer - bone cell interaction, and develop and test novel therapeutic agents for the treatment of skeletal complications associated with bone metastases.

Dr Aymen Idris is a pharmacologist and a lecturer in cancer associated bone disease at the Edinburgh Cancer Research Centre at the Institute of Genetics and Molecular Medicine. The focus of his research has been the discovery and development of novel therapeutic agents for the prevention and treatment of bone diseases

This seminar is directed at clinical and non-clinical researchers with strong background in basic science.